Opendata, web and dolomites

MOBIUS SIGNED

MØBIUS: Transforming medication management for improved patient safety

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MOBIUS project word cloud

Explore the words cloud of the MOBIUS project. It provides you a very rough idea of what is the project "MOBIUS" about.

integration    automation    automated    eliminating    integrating    brings    logistics    investment    companies    generate    class    unused    expenditures    stock    electronic    transform    packaging    enhanced    sufficient    13    medicine    fraction    flow    seal    exchange    dispensing    traceability    prescription    roi    dramatically    submission    hospital    dispensation    business    thula    20    reduces    waste    commercialization    2021    drugs    first    safety    proposition    integrates    errors    entry    saves    search    accountability    cumulative    inefficiencies    finalizing    sme    validating    countries    data    winning    medicines    loops    inst    plan    intends    health    market    time    commercial    oslash    award    realistic    jobs    iceland    company    linking    bius    improves    pharmaceuticals    wasting    excellence    q1    robots    removes    facilities       software    prescriptions    solutions    platform    manual    implementable    services    oecd    mission    patient    strategy    healthcare    drug    entire    designed    pharmacies    22    improvement    ensures    95    solution    security    medication   

Project "MOBIUS" data sheet

The following table provides information about the project.

Coordinator
THULA-NORRAENT HUGVIT EHF 

Organization address
address: GLERARGOTU 28
city: AKUREYRI
postcode: 600
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Iceland [IS]
 Project website http://thula.is
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-05-01   to  2018-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    THULA-NORRAENT HUGVIT EHF IS (AKUREYRI) coordinator 50˙000.00

Map

 Project objective

Thula is an award-winning IT company based in Iceland with the mission of providing first class e-health solutions for medication management, logistics and electronic exchange of healthcare information. Thula has developed MØBIUS, a unique software solution that can manage the entire medication flow of hospital pharmacies, long-term healthcare facilities or companies providing healthcare services and logistics. Pharmaceuticals account for 20% of overall healthcare expenditures in OECD countries but a significant fraction of this investment could be reduced by eliminating inefficiencies in drug management (e.g., errors in prescription and dispensation; waste of unused medicines). MØBIUS is an integration platform designed to transform medicine management through enhanced automation. By linking different systems in the medication- and logistics loops, MØBIUS dramatically reduces inefficiencies in stock management and increases patient safety and security. MØBIUS integrates Electronic Prescriptions, automated dispensing robots and distribution systems. It also ensures availability of sufficient drugs for the patient, processes drug dispensing effectively, removes time wasting, saves resources, allows easy access to medicine, brings on more security on the data compared to manual-based systems, and improves accountability and traceability. The objectives of the SME Inst project include finalizing and validating the development of MØBIUS by integrating and packaging advanced features; search of commercial partners in target EU countries; in-depth assessment of entry strategy into the EU healthcare market; and a realistic and implementable business plan. We expect MØBIUS will generate about 40 new jobs and a cumulative ROI of €5.95 in the first 4 years after commercialization in Q1 2021. This submission, an improvement of a previous call in which we achieved a Seal of Excellence (13.22), intends to further demonstrate MØBIUS’ approach and our company’s value proposition.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MOBIUS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MOBIUS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

MCBD (2019)

MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINE

Read More  

Genetta (2019)

Pole climbing solution to improve safety at work and to prevent fatal accidents in industrial climbing

Read More  

SmartDegrees (2020)

First anti-fraud plataform for the registration and certification of diplomas and academic certificates based in blockchain

Read More